BCTXL

BriaCell Therapeutics Corp. - Warrants · NASDAQ (us_market)

— · — · —

—

Price (last 5Y) · orange dots are splits

1W 2W 3W 1M 3M 6M 1Y 5Y 10Y 20Y MAX

Drawdown from ATH

—

normal range

30d return

—

30d realized vol

—%

Historical lean-in setups

since 2020 (DD ≥15%, bounce ≥15%)

Profile

← Back to dashboard

Quote typeEQUITY

Price rows0

Last error: no price data for BCTXL

No qualifying bottom-picking events since 2020.

No scored news yet for a sentiment trend.

No news yet for this ticker.

Fundamentals

as of 2026-05-31

Valuation

Market Cap—

Enterprise Value—

Trailing P/E—

Forward P/E—

PEG Ratio—

P/B0.22

P/S—

EV / Revenue—

EV / EBITDA—

Profitability

Gross Margin0.00%

Operating Margin0.00%

Profit Margin0.00%

ROE-179.21%

ROA-89.44%

Revenue Growth (YoY)—

Earnings Growth (YoY)—

Cash & Leverage

Total Cash$29.90M

Total Debt$0.00

Debt / Equity—

Current Ratio10.10

Free Cash Flow$-20.49M

Operating Cash Flow$-30.97M

Shareholders

Dividend Yield—

Payout Ratio—

% Held by Insiders—

% Held by Institutions—

Shares Outstanding—

Float6.41M

BCTXL

Price (last 5Y) · orange dots are splits

Profile

Historical Bottom-Picking Review

Related News

Fundamentals